Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALLI vs ALOGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALLI vs ALOGLIPTIN: Safety Overview

Metric ALLI ALOGLIPTIN
Total FAERS Reports 1,057 1,385
Deaths Reported 0 122
Death Rate N/A 8.8%
Hospitalizations 14 567
Average Patient Age 46.7 yrs 69.0 yrs
% Female Patients N/A 41.0%
FDA Approval Date N/A Jan 25, 2013
Manufacturer N/A Padagis Israel Pharmaceuticals Ltd
Route N/A ORAL
Marketing Status N/A Prescription